@Mimouchi61 @truesdale_matt @DannyN2223333 @scrowder https://t.co/5zTD7KTlnV Heres a study with a sample size of 1205 and a total of 20 cases of thrombosis and blood clots. Which would suggest an incidence rate of 1.6%.
@pdrpuff1 True that, There was a safety study done on bbv152 and others in Florida. I don’t recognize any of the names though. https://t.co/gHJyJZ9vFx
Daha Denek yaptıkları yetmemiş! Dünyayı aptal yerine koymak bu despotluk adeta! Gönüllü adı altında türlü çeşit dayatma yapıldı reklamlara ek Yazıklar olsun ! 2 yıl sonucunda işe yaramadığını ETİK analizler gösteriyor Manipüle edilmeyen veriler yetmemiş
"The commonly reported adverse events were in line with similar studies. We have concerns with the frequency of serious adverse effects. This work necessitates the need for further clinical assessments with larger sample sizes." https://t.co/b2feceI0iQ ht
RT @SenseReceptor: "Phase 3 suggested no association between serious adverse events and vaccine administration, but our results do not supp…
"Phase 3 suggested no association between serious adverse events and vaccine administration, but our results do not support this and further clinical assessments are highly recommended." https://t.co/b2feceI0iQ https://t.co/Lty6GtOPu6
RT @NavroopSingh_: Vaccine-associated complications: a comparative multicenter evaluation—which candidate vaccine is more safe in SARS COV…
RT @NavroopSingh_: Vaccine-associated complications: a comparative multicenter evaluation—which candidate vaccine is more safe in SARS COV…
RT @NavroopSingh_: Vaccine-associated complications: a comparative multicenter evaluation—which candidate vaccine is more safe in SARS COV…
RT @NavroopSingh_: Vaccine-associated complications: a comparative multicenter evaluation—which candidate vaccine is more safe in SARS COV…
RT @NavroopSingh_: Vaccine-associated complications: a comparative multicenter evaluation—which candidate vaccine is more safe in SARS COV…
Vaccine-associated complications: a comparative multicenter evaluation—which candidate vaccine is more safe in SARS COV II, Gam-COVID-Vac (Sputnik V), ChAdOx1 nCoV-19 (AstraZeneca), BBV152 (Covaxin), or BBIBP-CorV(Sinopharm)? https://t.co/PMbDrXF8tW